About Us
Aneurysms affect around 160 million people worldwide, according to the WHO.
Approximately 2% of the world’s population and up to 5% of people over 65 years old.
Since the beginning of the 1990s, the development of minimally invasive techniques for the treatment of cardiovascular diseases, revolutionized the surgical procedure and the results of the treatment of these conditions, creating a billion-dollar market.
On the other hand, this market still lacks lasting universal solutions that more broadly address different complexities and types of cases.
ARCHO was born out of these challenges.
Created to bridge the technological gaps in endovascular treatment of the different presentations of aortic and iliac aneurysms, Archo combines technology and innovation to deliver an exclusive, comprehensive solution that addresses the most critical limitations of current techniques: fixation, sealing, fatigue resistance, navigability, profile, and adaptation to complex anatomies.
On the other hand, this market still lacks lasting universal solutions that more broadly address different complexities and types of cases.
ARCHO was born out of these challenges.
Created to bridge the technological gaps in endovascular treatment of the different presentations of aortic and iliac aneurysms, Archo combines technology and innovation to deliver an exclusive, comprehensive solution that addresses the most critical limitations of current techniques: fixation, sealing, fatigue resistance, navigability, profile, and adaptation to complex anatomies.
